Work

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study

Year: 2013

Type: article

Study design: Observational Study

Source: The Lancet Neurology

DOI: 10.1016/s1474-4422(12)70323-x

Authors: Kimford J Meador, Gus A Baker, Nancy Browning, Morris J Cohen, Rebecca L Bromley, Jill Clayton-Smith, Laura A Kalayjian, Andres Kanner, Joyce D Liporace, Page B Pennell, Michael Privitera, David W Loring

Institutions: Emory University, University of Liverpool, Walton Centre, Emmes (United States), University of Manchester, University of Southern California, Rush University Medical Center, Riddle Hospital, Brigham and Women's Hospital, University of Cincinnati

Language: English

Topic: Pharmacological Effects and Toxicity Studies

Subfield: Pediatrics, Perinatology and Child Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Epilepsy Foundation, Pfizer, GlaxoSmithKline, Sanofi, Marinus Pharmaceuticals, Eisai, Epilepsiatutkimussäätiö, Epilepsy Society, National Institutes of Health, National Institute of Neurological Disorders and Stroke, UCB Pharma

Awards: G116153085, Neurodevelopmental Effects of Antiepileptic Drugs II, Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD), G7223345675, Neurodevelopment Effects of Antiepileptic Drugs, MONEAD Data and Statistical Center, G9000226801, G9000351020

OpenAlex ID: W1983142641

FWCI: 65.88

Cites: 36

Cited by: 839

Related to: 10